SCHEMBL7279703

SCHEMBL7279703

CC(C)C(CS(=O)(=O)NCc1ccccc1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 5/20 0.47
▸ CA2 P00918 3/20 0.47
▸ CA7 P43166 3/20 0.47
▸ CA14 Q9ULX7 3/20 0.47
▸ CA1 P00915 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.44
▸ OPRK1 P41145 1/20 0.44
▸ KEAP1 Q14145 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ CA9 Q16790 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7270211 0.85 CA12 (0.45) CA12CA2CA7CA14CA1
SCHEMBL10317146 0.81 CA12 (0.53) CA12CA2CA7CA14CA1
SCHEMBL7270371 0.80 CTSD (0.44) CA2
SCHEMBL13585095 0.78 CA2 (0.51) CA12CA2CA7CA14CA1
SCHEMBL6444689 0.78 CA2 (0.50) CA12CA2CA7CA14CA1
SCHEMBL13585100 0.78 CA2 (0.51) CA12CA2CA7CA14CA1
SCHEMBL5516790 0.76 HPGD (0.54) CA2CA1ALDH1A1TSHRCA9
SCHEMBL6444934 0.76 CA2 (0.47) CA12CA2CA7CA14CA1
SCHEMBL6444937 0.76 CA2 (0.47) CA12CA2CA7CA14CA1
SCHEMBL7653680 0.74 CPA3 (0.56) CA12CA2CA7CA14CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 — — EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 — — US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 — — US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 — — US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 — — EP disclosed
Send feedback